Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Nowak

Showing results (751-760 of 807) with videos related to

Pageof 81
Sort By:
Human Molecular Genetics|May 6, 2010
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regionsTao Yu, Zhongyou Li, Zhengping Jia, et al.
Annals of Clinical and Translational Neurology|March 11, 2020
Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experienceSarah J Beecroft, Kyle S Yau, Richard J N Allcock, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Cancer Research|November 24, 2001
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCRG R Anderson, B M Brenner, H Swede, et al.
American Journal of Human Genetics|November 27, 2010
Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with coresNyamkhishig Sambuughin, Kyle S Yau, Montse Olivé, et al.
The Journal of Cell Biology|May 27, 2009
Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actinKristen J Nowak, Gianina Ravenscroft, Connie Jackaman, et al.
Leukemia|December 22, 2018
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AMLDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Annals of Neurology|September 30, 2015
TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotypeS Donkervoort, M Papadaki, J M de Winter, et al.
Neurology|October 21, 2022
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia GravisVera Bril, Andrzej Szczudlik, Antanas Vaitkus, et al.
Pageof 81

Showing results (751-760 of 807) with videos related to

Sort By:
Pageof 81
Human Molecular Genetics|May 6, 2010
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regionsTao Yu, Zhongyou Li, Zhengping Jia, et al.
Annals of Clinical and Translational Neurology|March 11, 2020
Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experienceSarah J Beecroft, Kyle S Yau, Richard J N Allcock, et al.
Leukemia|January 3, 2017
Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cellsD T Saenz, W Fiskus, Y Qian, et al.
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Cancer Research|November 24, 2001
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCRG R Anderson, B M Brenner, H Swede, et al.
American Journal of Human Genetics|November 27, 2010
Dominant mutations in KBTBD13, a member of the BTB/Kelch family, cause nemaline myopathy with coresNyamkhishig Sambuughin, Kyle S Yau, Montse Olivé, et al.
The Journal of Cell Biology|May 27, 2009
Rescue of skeletal muscle alpha-actin-null mice by cardiac (fetal) alpha-actinKristen J Nowak, Gianina Ravenscroft, Connie Jackaman, et al.
Leukemia|December 22, 2018
Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AMLDyana T Saenz, Warren Fiskus, Taghi Manshouri, et al.
Annals of Neurology|September 30, 2015
TPM3 deletions cause a hypercontractile congenital muscle stiffness phenotypeS Donkervoort, M Papadaki, J M de Winter, et al.
Neurology|October 21, 2022
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia GravisVera Bril, Andrzej Szczudlik, Antanas Vaitkus, et al.
Pageof 81